376 related articles for article (PubMed ID: 27450011)
21. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children.
Latorre I; Díaz J; Mialdea I; Serra-Vidal M; Altet N; Prat C; Díez N; Escribano A; Casas I; Rodrigo C; Ausina V; Ruhwald M; Domínguez J
J Infect; 2014 Dec; 69(6):590-9. PubMed ID: 24975172
[TBL] [Abstract][Full Text] [Related]
22. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
[TBL] [Abstract][Full Text] [Related]
23. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
[TBL] [Abstract][Full Text] [Related]
24. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.
Kabeer BS; Raja A; Raman B; Thangaraj S; Leportier M; Ippolito G; Girardi E; Lagrange PH; Goletti D
BMC Infect Dis; 2011 May; 11():135. PubMed ID: 21595874
[TBL] [Abstract][Full Text] [Related]
25. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis.
Zhou Y; Zhang F; Shi H; Wu P; Zhou Y
Tuberculosis (Edinb); 2022 Sep; 136():102256. PubMed ID: 36113397
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Liang Y; Wang Y; Li H; Yang Y; Liu J; Yu T; Wu X
APMIS; 2016 Oct; 124(10):856-64. PubMed ID: 27523388
[TBL] [Abstract][Full Text] [Related]
27. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper.
Aabye MG; Latorre I; Diaz J; Maldonado J; Mialdea I; Eugen-Olsen J; Ravn P; Dominguez J; Ruhwald M
Eur Respir J; 2013 Aug; 42(2):495-503. PubMed ID: 23349445
[TBL] [Abstract][Full Text] [Related]
28. Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses.
Kimuda SG; Andia-Biraro I; Egesa M; Bagaya BS; Raynes JG; Levin J; Elliott AM; Cose S
PLoS One; 2017; 12(11):e0188396. PubMed ID: 29161328
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Standard E TB-Feron Enzyme-Linked Immunosorbent Assay for Diagnosis of Latent Tuberculosis Infection in Health Care Workers.
Kweon OJ; Lim YK; Kim HR; Kim TH; Lee MK
J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31533984
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
[TBL] [Abstract][Full Text] [Related]
31. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?
Goletti D; Raja A; Syed Ahamed Kabeer B; Rodrigues C; Sodha A; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
PLoS One; 2010 Sep; 5(9):e12577. PubMed ID: 20830287
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease.
Dolezalova K; Hadlova P; Ibrahimova M; Golias J; Baca L; Kopecka E; Sukholytka M; Koziar Vasakova M
Tuberculosis (Edinb); 2024 Jul; 147():102518. PubMed ID: 38739968
[TBL] [Abstract][Full Text] [Related]
33. Multiple cytokine analysis based on QuantiFERON-TB gold plus in different tuberculosis infection status: an exploratory study.
Zhang L; Yang Z; Wu F; Ge Q; Zhang Y; Li D; Gao M; Liu X
BMC Infect Dis; 2024 Jan; 24(1):28. PubMed ID: 38166667
[TBL] [Abstract][Full Text] [Related]
34. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.
Santin M; Morandeira-Rego F; Alcaide F; Rabuñal R; Anibarro L; Agüero-Balbín R; Casas-Garcia X; Pérez-Escolano E; Navarro MD; Sánchez F; Coira-Nieto A; Trigo-Daporta M; Martinez-Meñaca A; Gonzalez-Cuevas A; López-Prieto MD; Domínguez-Castellano A; Jové N;
Clin Microbiol Infect; 2016 Dec; 22(12):1007.e1-1007.e5. PubMed ID: 27647563
[TBL] [Abstract][Full Text] [Related]
35. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
[TBL] [Abstract][Full Text] [Related]
36. Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy.
Leem AY; Song JH; Lee EH; Lee H; Sim B; Kim SY; Chung KS; Kim EY; Jung JY; Park MS; Kim YS; Chang J; Kang YA
Sci Rep; 2018 Jan; 8(1):1159. PubMed ID: 29348638
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis.
Hong JY; Jung GS; Kim H; Kim YM; Lee HJ; Cho SN; Kim SK; Chang J; Kang YA
Int J Infect Dis; 2012 Dec; 16(12):e855-9. PubMed ID: 22959355
[TBL] [Abstract][Full Text] [Related]
39. A comparison of interferon-γ and IP-10 for the diagnosis of tuberculosis.
Holm LL; Rose MV; Kimaro G; Bygbjerg IC; Mfinanga SG; Ravn P; Ruhwald M
Pediatrics; 2014 Dec; 134(6):e1568-75. PubMed ID: 25422019
[TBL] [Abstract][Full Text] [Related]
40. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
